Related Experiment Videos
Multimodality treatment of locally advanced pancreatic cancer
D J Wagener1, P H de Mulder, J A Wils
1Division of Medical Oncology, University Hospital Nijmegen St Radboud, The Netherlands.
Abstract
Background:
The prognosis of locally advanced pancreatic cancer is poor (median survival 3-5 months). In view of the localized character of this disease several groups have explored the value of combined modality treatment. The conditions are that a good local treatment and an effective systemic treatment are available.
Patients And Methods:
The results of irradiation and of chemotherapy in advanced disease are reviewed.
Results:
An overview of combined modality treatment has been given.
Conclusions:
Results of combined modality treatment are superior to irradiation alone or to symptomatic treatment.